Cataract Eye Drops: The Dream That Dissolved Crystallized Proteins in the Eye

Once every few years, an idea emerges from the lab that sounds too good to be true: simple eye drops that can dissolve cataracts without surgery. Cataract, the clouding of the eye's lens with age, is the leading cause of blindness worldwide, affecting over 90 million people, and the only effective treatment is surgical removal of the lens and replacement with an artificial lens. Cataract surgery is the most common surgery in the world. But what if it could be skipped entirely?

In 2015, a team of researchers led by Ling Zhao from Sun Yat-sen University in China and the University of California, San Diego (UC San Diego) published a paper in Nature that generated enormous excitement. They identified a natural molecule called lanosterol that supposedly dissolved the crystallized proteins clouding the lens and restored its transparency. But this story, as we will see, is much more complex than a single exciting headline. It is a perfect example of why real science requires replication, and why hope alone is not enough.

What a Cataract Really Is

The eye's lens is a unique tissue in the body. To be completely transparent and refract light precisely, it is built from proteins called crystallins arranged in immense density and perfect geometric order. This is one of the rare cases where living tissue must be as transparent as glass.

• No protein turnover: Unlike most cells in the body, lens cells hardly ever replace their proteins. The crystallins you are born with accompany you for life.
• Cumulative exposure: Decades of UV radiation, oxidative stress, high blood sugar, and glycation cause cumulative damage to these proteins.
• Aggregation: Over time, crystallins lose their proper shape, stick to each other, and form clumps. These clumps scatter light instead of letting it pass through.
• The result: The lens becomes cloudy, yellowish, and the patient's vision gradually blurs until functional blindness.

The important point for readers of this site: cataract is essentially a protein aggregation disease, just as brain aging is linked to amyloid accumulation. This is one of the classic hallmarks of aging: the accumulation of damaged proteins that the body can no longer clear.

The Connection to Lanosterol: A Surprising Mechanism

Zhao and his team's idea did not come out of nowhere. It began with a clinical observation. The researchers examined children suffering from a hereditary form of congenital cataract, a rare condition where infants are born with cloudy lenses. They discovered that these children shared a mutation in an enzyme called lanosterol synthase, the enzyme that produces lanosterol in the body.

The logic was elegant: if an inability to produce lanosterol causes cataracts, perhaps lanosterol is a molecule that protects the lens from protein aggregation. Lanosterol is an intermediate molecule in cholesterol production and is naturally present in the lens at relatively high concentrations.

The proposed mechanism is called a chemical chaperone. In healthy cells, there are proteins called chaperones whose job is to help other proteins fold correctly and prevent them from aggregating. The hypothesis: lanosterol binds to the aggregating crystallins and breaks the clumps back down into individual soluble proteins. If true, this is a revolutionary idea—not just stopping the decline but reversing it.

This is precisely what makes this story so relevant to the field of reversing aging: if a small molecule can dissolve protein aggregates in the eye, perhaps a similar principle could work on amyloid in the brain or on aggregating proteins in other tissues.

The Current Evidence

Study 1: Zhao et al., Nature 2015

This is the original study, published in volume 523 of Nature. The researchers tested lanosterol at three levels:

• In vitro: Lanosterol, but not cholesterol, significantly reduced pre-formed crystallin protein aggregates.
• In rabbits: In rabbit lenses with cataracts, 11 out of 13 rabbits progressed from severe or significant cataract to mild or no cataract within just 6 days. This was the data that made headlines.
• In dogs: Dogs with natural cataracts treated with lanosterol drops for 6 weeks showed a decrease in cataract severity and an increase in lens transparency.

This result, if correct, was supposed to completely change cataract treatment.

Study 2: Replication Failure, Scientific Reports 2019

And here comes the side that this site is committed to presenting honestly. In 2019, a team of researchers published a paper in Scientific Reports (from the Nature group) titled Failure of Oxysterols Such as Lanosterol to Restore Lens Clarity from Cataracts. The results were unequivocally in the opposite direction:

• 40 human lenses with age-related cataract were incubated with lanosterol at a concentration of 25 millimolar for 6 days. The result: lanosterol failed to dissolve the aggregating proteins and did not restore transparency to the lens nucleus.
• Incubation of human lenses aged 47 and 60 with lanosterol and other oxysterols did not increase levels of soluble protein or decrease levels of insoluble protein.
• The researchers' conclusion: none of the three experiments provided evidence that lanosterol has anti-cataract activity or that it binds to the aggregating protein to dissolve it.

In simple words: when the magic was attempted to be replicated in real human lenses, it did not happen. This is a deep gap between the hope of 2015 and the reality in an independent lab in 2019.

What About Human Trials?

This is perhaps the most important point. To date, there is no randomized, controlled clinical trial in humans showing that lanosterol drops treat cataracts. There have been isolated and questionable case reports, but no large, well-controlled, peer-reviewed study confirming benefit in humans. All we have are animal results that were not replicated in human lenses.

Why Is It So Hard to Dissolve an Aggregated Protein

The failure to replicate is not accidental, and it has a deep biochemical explanation. Protein aggregation is often an almost irreversible process:

• The clumps are energetically stable: When proteins aggregate, they form very stable structures thermodynamically. To break them apart, one must overcome a high energy barrier, and a small molecule is not always capable of doing so.
• Permanent chemical damage: In age-related cataract, crystallins are not just aggregating; they are also chemically damaged irreversibly through oxidation, glycation, and cross-linking. A chemical chaperone might prevent aggregation, but it cannot repair a protein whose side chains have already been destroyed.
• The difference between prevention and cure: It is possible that lanosterol can prevent aggregation in a young lens but is powerless against an old human lens that is already cloudy. This would also explain why results in young animals with hereditary cataracts were not replicated in old human lenses.

Should You Look to Buy Lanosterol Drops?

The clear answer: No, not today. Here is why genuine caution is needed:

• No approved product: No medical authority in the world, not the FDA or the EMA, has approved lanosterol drops for treating cataracts in humans. Any product sold online under this name is not evidence-based.
• Solubility problem: Lanosterol is a very fatty molecule that is almost insoluble in water. One of the criticisms of the original study was that it is very difficult to deliver it into the lens at an effective concentration via a drop.
• Delaying proven treatment: The greatest danger is that a person with advanced cataract will delay surgery that can restore their vision in favor of an unproven treatment. An untreated cataract can lead to complete blindness.
• Cataract surgery is very safe and effective: Today, cataract surgery is a short, safe procedure with a success rate of over 95%, and it usually restores excellent vision within days. This is a very high bar that any magic drop would need to meet.

What to Take from the Research

1. If you have a cataract that interferes with vision, see an ophthalmologist and consider surgery. This is the only proven treatment today, and it is very safe and effective. Do not delay it for unapproved drops.
2. If you are healthy, focus on prevention. Protection from UV radiation with quality sunglasses, blood sugar control, avoiding smoking, and a diet rich in antioxidants all reduce the rate of cataract formation.
3. Do not buy "anti-cataract drops" online. There is no evidence-based product, and some of these products may even cause eye damage.
4. Follow the research, but with a critical eye. If and when a randomized, controlled clinical trial in humans with positive results is published, that will be a moment to celebrate. Until then, it is a promising direction, not a solution.

The Broader Perspective

The lanosterol story is an excellent lesson in the difference between an exciting discovery and a proven treatment. A single headline in Nature in 2015 shook the world, but real science is not measured by a single headline; it is measured by replication. And when replication was attempted, in real human lenses, the result did not hold.

This does not mean the idea is dead. It is possible that lanosterol or a similar molecule does work under certain conditions, on a specific type of cataract, or at an early stage of the disease. The idea that protein aggregates can be dissolved with a small molecule is a powerful one, and if proven, the implications will extend far beyond the eye, to the brain, heart, and any tissue where proteins aggregate with age.

But until that happens, the critical truth must remain on the table: cataract eye drops are currently a promising scientific dream that failed replication, not an available treatment. In the field of reversing aging, where marketing runs far ahead of evidence, the ability to distinguish between the two is the reader's best defense. A promising discovery not yet proven in humans is exactly that: promising, and not yet proven.

References:
Science (AAAS) - Eye drops could dissolve cataracts
Nature 2015 - Lanosterol reverses protein aggregation in cataracts
Scientific Reports 2019 - Failure of Oxysterols Such as Lanosterol to Restore Lens Clarity from Cataracts